SHERRILL J SLICHTER
Medical Practice at Eastlake Ave, Seattle, WA

License number
Washington MD00010225
Category
Medical Practice
Type
Hematology
Address
Address
825 Eastlake Ave EAST, Seattle, WA 98109
Phone
(206) 288-1012
(206) 543-6420

Personal information

See more information about SHERRILL J SLICHTER at radaris.com
Name
Address
Phone
Sherrill Slichter
14710 Glen Acres Rd SW #70, Vashon, WA 98070
Sherrill Slichter
Seattle, WA
(206) 567-5750
Sherrill Slichter
Coupeville, WA
(360) 678-6922
Sherrill J Slichter, age 87
14710 Glen Acres Rd SW, Vashon, WA 98070
(206) 567-5750
Sherrill J Slichter, age 87
2108 Madrona Way, Coupeville, WA 98239
(360) 678-6922

Professional information

Sherrill Jeane Slichter Photo 1

Sherrill Jeane Slichter, Seattle WA

Specialties:
Internal Medicine, Hematology
Work:
Puget Sound Blood Ctr
921 Terry Ave, Seattle, WA 98104 Seattle Cancer Care Alliance
825 Eastlake Ave E, Seattle, WA 98109 University of Washington Medical Center
1959 Ne Pacific St, Seattle, WA 98195
Education:
George Washington University (1963)


Sherrill J Slichter Photo 2

Dr. Sherrill J Slichter, Seattle WA - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
825 Eastlake Ave E, Seattle 98109
(206) 288-1012 (Phone)
Certifications:
Internal Medicine, 1969
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
825 Eastlake Ave E, Seattle 98109
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
George Washington University School Of Medicine
Graduated: 1963
Mt Sinai Hospital
Graduated: 1964
Graduated: 1965
Parkland Memorial Hospital
Graduated: 1967
University Wash Hospital
Graduated: 1968


Sherrill Slichter Photo 3

Antithrombotic Pharmaceutical Compositions And Method Of Use

US Patent:
4285945, Aug 25, 1981
Filed:
Sep 17, 1979
Appl. No.:
6/076510
Inventors:
Sherrill J. Slichter - Seattle WA
International Classification:
A61K 31505
US Classification:
424251
Abstract:
Antithrombotic pharmaceutical compositions containing, as a combination of active ingredients, 2,6-bis-(diethanolamino)-4-piperidino-pyrimido[5,4-d]pyrimidine and sulfinpyrazone, and a method of preventing or relieving thrombosis therewith.